| ［1］ |
Romagnoli C， Iantomasi T， Brandi ML. Available in vitro models for human satellite cells from skeletal muscle［J］. Int J Mol Sci， 2021， 22（24）：13221. DOI： 10.3390/ijms222413221.
|
| ［2］ |
Shan H， Gao X， Zhang M，et al. Injectable ROS-scavenging hydrogel with MSCs promoted the regeneration of damaged skeletal muscle［J］. J Tissue Eng， 2021， 12：20417314211031378. DOI： 10.1177/20417314211031378.
|
| ［3］ |
Kalyani RR， Corriere M， Ferrucci L. Age-related and disease-related muscle loss： the effect of diabetes，obesity，and other diseases［J］. Lancet Diabetes Endocrinol， 2014， 2（10）：819-29. DOI： 10.1016/S2213-8587（14）70034-8.
|
| ［4］ |
Dolly A， Dumas JF， Servais S. Cancer cachexia and skeletal muscle atrophy in clinical studies： what do we really know？ ［J］. J Cachexia Sarcopenia Muscle， 2020， 11（6）：1413-1428. DOI： 10.1002/jcsm.12633.
|
| ［5］ |
Shu LZ， Zhang XL， Ding YD，et al. From inflammation to bone formation： the intricate role of neutrophils in skeletal muscle injury and traumatic heterotopic ossification［J］. Exp Mol Med， 2024， 56（7）：1523-1530. DOI： 10.1038/s12276-024-01270-7.
|
| ［6］ |
Yao M， Zhang J， Li Z，et al. Liraglutide protects nucleus pulposus cells against high-glucose induced apoptosis by activating PI3K/Akt/mTOR/Caspase-3 and PI3K/Akt/GSK3β/Caspase-3 signaling pathways［J］. Front Med （Lausanne）， 2021， 8：630962. DOI： 10.3389/fmed.2021.630962.
|
| ［7］ |
Zhao Y， Chard Dunmall LS， Cheng Z，et al. Natural products targeting glycolysis in cancer［J］. Front Pharmacol， 2022， 13：1036502. DOI： 10.3389/fphar.2022.1036502.
|
| ［8］ |
Rubino R， Squillero G， Prever L，et al. Decoding class II PI3K signaling： from membrane identity to human disease［J］. Biochim Biophys Acta Mol Cell Biol Lipids， 2026， 1871（1）：159693. DOI： 10.1016/j.bbalip.2025.159693.
|
| ［9］ |
He Y， Sun MM， Zhang GG，et al. Targeting PI3K/Akt signal transduction for cancer therapy［J］. Signal Transduct Target Ther， 2021， 6（1）：425. DOI： 10.1038/s41392-021-00828-5.
|
| ［10］ |
Burillo J， Marqués P， Jiménez B，et al. Insulin resistance and diabetes mellitus in Alzheimer's disease［J］. Cells， 2021， 10（5）：1236. DOI： 10.3390/cells10051236.
|
| ［11］ |
Hashemi M， Taheriazam A， Daneii P，et al. Targeting PI3K/Akt signaling in prostate cancer therapy［J］. J Cell Commun Signal， 2023， 17（3）：423-443. DOI： 10.1007/s12079-022-00702-1.
|
| ［12］ |
Dong C， Wu J， Chen Y，et al. Activation of PI3K/AKT/mTOR pathway causes drug resistance in breast cancer［J］. Front Pharmacol， 2021， 12：628690. DOI： 10.3389/fphar.2021.628690.
|
| ［13］ |
Sirico M， D'Angelo A， Gianni C，et al. Current state and future challenges for PI3K inhibitors in cancer therapy［J］. Cancers （Basel）， 2023， 15（3）：703. DOI： 10.3390/cancers15030703.
|
| ［14］ |
Deng RM， Zhou J. The role of PI3K/AKT signaling pathway in myocardial ischemia-reperfusion injury［J］. Int Immunopharmacol， 2023， 123：110714. DOI： 10.1016/j.intimp.2023.110714.
|
| ［15］ |
Miricescu D， Balan DG， Tulin A，et al. PI3K/AKT/mTOR signalling pathway involvement in renal cell carcinoma pathogenesis （Review）［J］. Exp Ther Med， 2021， 21（5）：540. DOI： 10.3892/etm.2021.9972.
|
| ［16］ |
Acosta-Martinez M， Cabail MZ. The PI3K/Akt pathway in meta-inflammation［J］. Int J Mol Sci， 2022， 23（23）：15330. DOI： 10.3390/ijms232315330.
|
| ［17］ |
Montazeri M， Zarkesh M， Zadeh-Vakili A，et al. Association of physical activity with increased PI3K and Akt mRNA levels in adipose tissues of obese and non-obese adults［J］. Sci Rep， 2023， 13（1）：9291. DOI： 10.1038/s41598-023-36365-0.
|
| ［18］ |
DuBois JC， Ray AK， Gruber RC，et al. Akt3-mediated protection against inflammatory demyelinating disease［J］. Front Immunol， 2019， 10：1738. DOI： 10.3389/fimmu.2019.01738.
|
| ［19］ |
Mohás A， Krencz I， Váradi Z，et al. In situ analysis of mTORC1/C2 and metabolism-related proteins in pediatric osteosarcoma［J］. Pathol Oncol Res， 2022， 28：1610231. DOI： 10.3389/pore.2022.1610231.
|
| ［20］ |
Cohen P， Frame S. The renaissance of GSK3［J］. Nat Rev Mol Cell Biol， 2001， 2（10）：769-776. DOI： 10.1038/35096075.
|
| ［21］ |
Xia H， Chen Y， Li H，et al. Combined magnesium and silicon ions synergistically promote functional regeneration of skeletal muscle by regulating satellite cell fate［J］. Regen Biomater， 2025， 12：rbaf008. DOI： 10.1093/rb/rbaf008.
|
| ［22］ |
Scala P， Rehak L， Giudice V，et al. Stem cell and macrophage roles in skeletal muscle regenerative medicine［J］. Int J Mol Sci， 2021， 22（19）：10867. DOI： 10.3390/ijms221910867.
|
| ［23］ |
|
| ［24］ |
Teng H， Liu Y， Hao R，et al. The mechanism of EGF in promoting skeletal muscle post-injury regeneration［J］. Differentiation， 2025， 143：100862. DOI： 10.1016/j.diff.2025.100862.
|
| ［25］ |
Sorrentino S， Barbiera A， Proietti G，et al. Inhibition of phosphoinositide 3-kinase/protein kinase B signaling hampers the vasopressin-dependent stimulation of myogenic differentiation［J］. Int J Mol Sci， 2019， 20（17）：4188. DOI： 10.3390/ijms20174188.
|
| ［26］ |
Zhang RX， Zhai YY， Ding RR，et al. FNDC1 is a myokine that promotes myogenesis and muscle regeneration［J］. EMBO J， 2025， 44（1）：30-53. DOI： 10.1038/s44318-024-00285-0.
|
| ［27］ |
Zhu A， Liu N， Shang Y，et al. Signaling pathways of adipose stem cell-derived exosomes promoting muscle regeneration［J］. Chin Med J （Engl）， 2022， 135（21）：2525-2534. DOI： 10.1097/CM9.0000000000002404.
|
| ［28］ |
Wu C， Zheng X， Li Q，et al. Atrophy masseter recovery by electrical stimulation mediated M2-Like macrophage polarisation via JAK/PI3K/Akt pathway［J］. J Cachexia Sarcopenia Muscle， 2025， 16（4）：e70048. DOI： 10.1002/jcsm.70048.
|
| ［29］ |
Shang T， Xu H， Yao X，et al. Dual role of macrophages in skeletal muscle atrophy： mechanisms and therapeutic strategies［J］. Biochem Pharmacol， 2026， 244：117589. DOI： 10.1016/j.bcp.2025.117589.
|
| ［30］ |
Liu M， Huang X， Tian Y，et al. Phosphorylated GSK-3β protects stress-induced apoptosis of myoblasts via the PI3K/Akt signaling pathway［J］. Mol Med Rep， 2020， 22（1）：317-327. DOI： 10.3892/mmr.2020.11105.
|
| ［31］ |
Xie D， Li JH， Zhong YL，et al. Role of TRPC6 in apoptosis of skeletal muscle ischemia/reperfusion injury［J］. Cell Signal， 2024， 121：111289. DOI： 10.1016/j.cellsig.2024.111289.
|
| ［32］ |
von Maltzahn J， Bentzinger CF， Rudnicki MA. Wnt7a-Fzd7 signalling directly activates the Akt/mTOR anabolic growth pathway in skeletal muscle［J］. Nat Cell Biol， 2011， 14（2）：186-191. DOI： 10.1038/ncb2404.
|
| ［33］ |
Park J， Choi H， Shim K. Inhibition of GSK3β promotes proliferation and suppresses apoptosis of porcine muscle satellite cells［J］. Animals （Basel）， 2022， 12（23）：3328. DOI： 10.3390/ani12233328.
|
| ［34］ |
Ge X， Zhang Y， Jiang H. Signaling pathways mediating the effects of insulin-like growth factor-I in bovine muscle satellite cells［J］. Mol Cell Endocrinol， 2013， 372（1-2）：23-29. DOI： 10.1016/j.mce.2013.03.017.
|
| ［35］ |
Fang X， Xu H， Fan Z，et al. Puerarin promotes the migration and differentiation of myoblasts by activating the FAK and PI3K/Akt signaling pathways［J］. Biology （Basel）， 2025， 14（1）：102. DOI： 10.3390/biology14010102.
|
| ［36］ |
Chang TK， Huang LC， Kuo YH，et al. Antcin K ameliorates cardiotoxin-induced skeletal muscle injury and inflammation via IL-10 regulation［J］. Int J Biol Sci， 2025， 21（6）：2493-2507. DOI： 10.7150/ijbs.107343.
|
| ［37］ |
Jo SI， Park YS， Chang Y，et al. Effects of the purified dry extract of fermented ginseng BST204 on muscle fiber regeneration［J］. Biochem Biophys Rep， 2023， 35：101525. DOI： 10.1016/j.bbrep.2023.101525.
|
| ［38］ |
Lin KC， Yip HK， Shao PL，et al. Combination of adipose-derived mesenchymal stem cells （ADMSC） and ADMSC-derived exosomes for protecting kidney from acute ischemia-reperfusion injury［J］. Int J Cardiol， 2016， 216：173-185. DOI： 10.1016/j.ijcard.2016.04.061.
|
| ［39］ |
Guo R， Wu Z， Liu A，et al. Hypoxic preconditioning-engineered bone marrow mesenchymal stem cell-derived exosomes promote muscle satellite cell activation and skeletal muscle regeneration via the miR-210-3p/KLF7 mechanism［J］. Int Immunopharmacol， 2024， 142（Pt B）：113143. DOI： 10.1016/j.intimp.2024.113143.
|
| ［40］ |
Lim CH， Luu TS， Phoung LQ，et al. Satellite cell activation and mTOR signaling pathway response to resistance and combined exercise in elite weight lifters［J］. Eur J Appl Physiol， 2017， 117（11）：2355-2363. DOI： 10.1007/s00421-017-3722-x.
|
| ［41］ |
Feng L， Li B， Xi Y，et al. Aerobic exercise and resistance exercise alleviate skeletal muscle atrophy through IGF-1/IGF-1R-PI3K/Akt pathway in mice with myocardial infarction［J］. Am J Physiol Cell Physiol， 2022， 322（2）：C164-C176. DOI： 10.1152/ajpcell.00344.2021.
|
| ［42］ |
Sisto M， Lisi S. Towards a unified approach in autoimmune fibrotic signalling pathways［J］. Int J Mol Sci， 2023， 24（10）：9060. DOI： 10.3390/ijms24109060.
|
| ［43］ |
Li HY， Zhang QG， Chen JW，et al. The fibrotic role of phosphatidylinositol-3-kinase/Akt pathway in injured skeletal muscle after acute contusion［J］. Int J Sports Med， 2013， 34（9）：789-794. DOI： 10.1055/s-0032-1333284.
|
| ［44］ |
Yu X， Cao J， Wang B，et al. Silencing PIM1 inhibits ENO1-induced Akt activation and attenuates fibrillogenesis during spinal cord injury-induced skeletal muscle atrophy［J］. J Biol Chem， 2025， 301（8）：110398. DOI： 10.1016/j.jbc.2025.110398.
|
| ［45］ |
Kang J， Benjamin DI， Guo Q，et al. Cellular survivorship bias as a mechanistic driver of muscle stem cell aging［J］. Science， 2026， 391（6784）：517-521. DOI： 10.1126/science.ads9175.
|
| ［46］ |
Yazid MD， Hung-Chih C. Perturbation of PI3K/Akt signaling affected autophagy modulation in dystrophin-deficient myoblasts［J］. Cell Commun Signal， 2021， 19（1）：105. DOI： 10.1186/s12964-021-00785-0.
|
| ［47］ |
Duan T， Jia S， Zhou D，et al. ATP1B4 as a candidate upstream regulator of muscle atrophy in diabetic sarcopenia via PI3K/Akt/mTOR-mediated autophagy［J］. Int J Biochem Cell Biol， 2025， 189：106869. DOI： 10.1016/j.biocel.2025.106869.
|